Prof. Christoph Wanner is Professor of Medicine and head of the Division of Nephrology at the University Hospital of Würzburg, Germany

His research in the field of diabetic kidney disease, lipid disorders, and rare kidney diseases has been published in more than 800 pubmed referenced scientific papers and articles (HI 89). He has been PI of the 4D study and steering committee member of the SHARP and REVEAL trials. He is also steering committee member of the EMPA-REG Outcome, the EMPEROR & the EMPA-KIDNEY studies as well as the CARMELINA trial aiming in slowing the progression of kidney disease and improving cardiovascular outcomes.

He is member of several editorial boards of kidney journals and has been Associate Editor of the Clinical Journal of the America Society of Nephrology as well as Editor-in-Chief of the Journal of Renal Nutrition until recently.

In 2012 he received a doctor honoris causa from the Charles University of Prague. He has received the 2016 Award from the ERA-EDTA for Outstanding Clinical Contributions to Nephrology and in 2018 the Franz Volhard medaille, the highest award from the German Society of Nephrology. Dr. Wanner is President of the ERA-EDTA, being in office June 2020-2023.